New Lung Cancer Treatment
FDA Grants Approval to Trastuzumab Deruxtecan for HER2 Lung Cancer
Lung cancer patients now have another treatment option. For those tumors carrying HER2 mutations, can now be treated with trastuzumab deruxtecan. This drug is [...]
Lung Cancer Treatment Side Effects Prevented with Genetic Discovery
Lung cancer is one of the deadliest forms of cancers prevalent globally. Immunotherapy has emerged as one of the most effective ways to control this disease. [...]
Plant Compound Berberine May Help Fight Lung Cancer
Lung cancer is the leading cause of cancer related deaths among men and women and the scientific community continues to make efforts to find new ways for lung [...]
FDA Approves FoundationOne CDx in Non-Small Cell Lung Cancer
U.S. Food and Drug Administration (FDA) has approved the FoundationOne CDx as a companion diagnostic to guide treatment selection for patients with non-small [...]
Study Finds New Possibilities for Lung Cancer Treatment in ‘Never Smokers’
Smoking is the well-known reason for causing lung cancer among a significant amount of people. But, there are also those lung cancer patients who have never [...]
Robotic Surgery for Lung Cancer: What You Need to Know
In today’s article, we are taking a close look at robotic surgery for lung cancer. Robotic lung surgery was introduced back in 2002 and the technique is [...]
Takeda’s Exkivity Approved by FDA for Rare form of Lung Cancer
Takeda Pharmaceutical Co. Ltd. becomes the first one to get FDA approval for an oral drug targeted against rare form of non-small cell lung cancer. FDA has [...]
Chemotherapy and Immunotherapy Combination to Provide Effective Lung Cancer Treatment
According to a study published in Science Translational Medicine, a combination of two cancer treatments could provide effective treatment for lung cancer by [...]
Indian Scientists Develop 3D Robotic Motion Phantom for Lung Cancer Treatment
Indian scientists have developed a novel three-dimensional robotic motion phantom that is capable of reproducing human lung motion. This robotic motion has [...]
FDA Approves First Targeted Therapy for Lung Cancer with Specific Genetic Mutation
The U.S. Food and Drug Administration has approved Lumakras (sotorasib) as first treatment for non-small cell lung cancer patients whose tumors have specific [...]
FDA Approves Libtayo as Monotherapy for Advanced NSCLC
Lung cancer is one of the leading causes of cancer-related deaths worldwide. In the year 2020, an estimated 225,000 new cases were diagnosed in the United [...]
NICE Recommends Keytruda Plus Chemo for NSCLC Treatment
National Institute for Health and Care Excellence (NICE) has recommended Keytruda, alongside a combination of pemetrexed and platinum chemotherapy for [...]